ZA939118B - Processes for preparing 2-cyano-3-hydroxy-propenamides and pharmaceutical compositions containing them - Google Patents

Processes for preparing 2-cyano-3-hydroxy-propenamides and pharmaceutical compositions containing them

Info

Publication number
ZA939118B
ZA939118B ZA939118A ZA939118A ZA939118B ZA 939118 B ZA939118 B ZA 939118B ZA 939118 A ZA939118 A ZA 939118A ZA 939118 A ZA939118 A ZA 939118A ZA 939118 B ZA939118 B ZA 939118B
Authority
ZA
South Africa
Prior art keywords
propenamides
cyano
hydroxy
preparing
processes
Prior art date
Application number
ZA939118A
Other languages
English (en)
Inventor
Elizabeth Anne Kuo
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA939118B publication Critical patent/ZA939118B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA939118A 1993-01-05 1993-12-06 Processes for preparing 2-cyano-3-hydroxy-propenamides and pharmaceutical compositions containing them ZA939118B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939300083A GB9300083D0 (en) 1993-01-05 1993-01-05 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA939118B true ZA939118B (en) 1995-01-18

Family

ID=10728304

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939118A ZA939118B (en) 1993-01-05 1993-12-06 Processes for preparing 2-cyano-3-hydroxy-propenamides and pharmaceutical compositions containing them

Country Status (33)

Country Link
US (1) US5346912A (sl)
EP (1) EP0606175B1 (sl)
JP (1) JP3334988B2 (sl)
KR (1) KR100295717B1 (sl)
CN (1) CN1042935C (sl)
AT (1) ATE128968T1 (sl)
AU (1) AU663017B2 (sl)
BR (1) BR9400017A (sl)
CA (1) CA2112866C (sl)
CZ (1) CZ283948B6 (sl)
DE (1) DE69400024T2 (sl)
DK (1) DK0606175T3 (sl)
EE (1) EE03001B1 (sl)
ES (1) ES2078130T3 (sl)
FI (1) FI106553B (sl)
GB (1) GB9300083D0 (sl)
GR (1) GR3017723T3 (sl)
HR (1) HRP940006B1 (sl)
HU (1) HU216835B (sl)
IL (1) IL107788A (sl)
LT (1) LT3766B (sl)
LV (1) LV10712B (sl)
MX (1) MX9400274A (sl)
NO (1) NO300839B1 (sl)
NZ (1) NZ250520A (sl)
PL (1) PL175135B1 (sl)
RU (1) RU2126387C1 (sl)
SI (1) SI9300686A (sl)
SK (1) SK280508B6 (sl)
TW (1) TW259785B (sl)
UA (1) UA40573C2 (sl)
YU (1) YU49047B (sl)
ZA (1) ZA939118B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006153A1 (en) * 1998-07-28 2000-02-10 Smithkline Beecham Corporation Propenamides as ccr5 modulators
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
AR068063A1 (es) 2007-08-27 2009-11-04 Basf Plant Science Gmbh Co mpuestos de pirazol para controlar plagas de invertebrados
AU2009295936B2 (en) 2008-09-24 2014-07-17 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2011003793A1 (en) 2009-07-06 2011-01-13 Basf Se Pyridazine compounds for controlling invertebrate pests
EP2451804B1 (en) 2009-07-06 2014-04-30 Basf Se Pyridazine compounds for controlling invertebrate pests
WO2011009804A2 (en) 2009-07-24 2011-01-27 Basf Se Pyridine derivatives compounds for controlling invertebrate pests
WO2015077535A2 (en) 2013-11-22 2015-05-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases
CN105693574B (zh) * 2014-11-25 2017-12-19 中国科学院大连化学物理研究所 2‑烷硫基烯酰胺衍生物及其合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
DE3534440A1 (de) 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4888357A (en) 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
HU222234B1 (hu) * 1990-05-18 2003-05-28 Aventis Pharma Deutschland Gmbh. Eljárás izoxazol-4-karbonsav-amidok és hidroxi-alkilidén-cián-ecetsav-amidok, a vegyületeket tartalmazó gyógyászati készítmények és az ismert vegyületeket tartalmazó rákellenes hatású gyógyszerkészítmények előállítására
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide

Also Published As

Publication number Publication date
DK0606175T3 (da) 1996-02-19
CN1097005A (zh) 1995-01-04
ATE128968T1 (de) 1995-10-15
PL301774A1 (en) 1994-07-11
RU94000064A (ru) 1996-07-10
SK149593A3 (en) 1994-12-07
EP0606175B1 (fr) 1995-10-11
NO940020L (sl) 1994-07-06
YU49047B (sh) 2003-07-07
CZ283948B6 (cs) 1998-07-15
DE69400024T2 (de) 1996-04-04
AU663017B2 (en) 1995-09-21
MX9400274A (es) 1994-08-31
SI9300686A (en) 1994-09-30
CA2112866C (fr) 2007-03-13
NO300839B1 (no) 1997-08-04
NO940020D0 (no) 1994-01-04
CA2112866A1 (fr) 1994-07-06
SK280508B6 (sk) 2000-03-13
HU216835B (hu) 1999-09-28
HRP940006A2 (en) 1996-10-31
RU2126387C1 (ru) 1999-02-20
HRP940006B1 (en) 1999-12-31
FI940031A (fi) 1994-07-06
EE03001B1 (et) 1997-06-16
CN1042935C (zh) 1999-04-14
FI940031A0 (fi) 1994-01-04
NZ250520A (en) 1996-08-27
HUT71471A (en) 1995-11-28
KR940018363A (ko) 1994-08-16
YU82593A (sh) 1996-07-24
DE69400024D1 (de) 1995-11-16
US5346912A (en) 1994-09-13
KR100295717B1 (ko) 2001-11-05
EP0606175A1 (fr) 1994-07-13
GR3017723T3 (en) 1996-01-31
BR9400017A (pt) 1994-08-02
ES2078130T3 (es) 1995-12-01
LV10712B (en) 1995-12-20
LTIP1634A (en) 1995-02-27
JP3334988B2 (ja) 2002-10-15
IL107788A (en) 1998-08-16
TW259785B (en) 1995-10-11
CZ292193A3 (en) 1994-07-13
IL107788A0 (en) 1994-02-27
FI106553B (fi) 2001-02-28
AU5213093A (en) 1994-07-14
LV10712A (lv) 1995-06-20
HU9400033D0 (en) 1994-05-30
GB9300083D0 (en) 1993-03-03
PL175135B1 (pl) 1998-11-30
LT3766B (en) 1996-03-25
UA40573C2 (uk) 2001-08-15
JPH06211793A (ja) 1994-08-02

Similar Documents

Publication Publication Date Title
DK0778277T3 (da) Substituerede heterocycliske derivater som CRF antagonister
IL103875A0 (en) Piperazinyl-and piperidinyl-cyclohexanol derivatives and pharmaceutical compositions containing the same
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
CS183091A3 (en) Cephalosporins, having in the position 3 a propenyl radical substituted byquaternary ammonium, process of their preparation, their use as medicaments andpharmaceutical compositions in which said cephalosporins are comprised
ZA939118B (en) Processes for preparing 2-cyano-3-hydroxy-propenamides and pharmaceutical compositions containing them
DE69231815T2 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
SI0870761T1 (sl) Derivati tiokolhicina, ki delujejo proti vnetju in sproščajo mišice
DE60104986D1 (de) Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis
IL108200A0 (en) New preparation process for sulphurated derivatives of imidazole and the new intermediates obtained
GB9202139D0 (en) Improvements in or relating to organic compounds
DE69229017T2 (de) Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung
DK0552631T3 (da) Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider
TW221988B (sl)
MY110894A (en) New pyrazolylpryrazoles, processes for their preparation, as well as intermediates, and thier use as herbicides